Karine Breckpot

Karine Breckpot

Vrije Universiteit Brussel

H-index: 62

Europe-Belgium

About Karine Breckpot

Karine Breckpot, With an exceptional h-index of 62 and a recent h-index of 42 (since 2020), a distinguished researcher at Vrije Universiteit Brussel, specializes in the field of Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels

The development of Nanobodies against the next-generation immune checkpoint TIGIT with diagnostic and therapeutic potential

Immune checkpoints

Assessment of Connexin43 Hemichannel Functionality Based on Cytosolic Uptake of Yo-Pro1

Human PD-L1-binding immunoglobulins

Identification of tumor peptides for therapeutic mRNA vaccination in a mouse multiple myeloma model

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in acute myeloid leukemia

Karine Breckpot Information

University

Vrije Universiteit Brussel

Position

___

Citations(all)

11282

Citations(since 2020)

5985

Cited By

7213

hIndex(all)

62

hIndex(since 2020)

42

i10Index(all)

126

i10Index(since 2020)

102

Email

University Profile Page

Vrije Universiteit Brussel

Karine Breckpot Skills & Research Interests

Immunology

Top articles of Karine Breckpot

Title

Journal

Author(s)

Publication Date

Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels

European Journal of Pharmaceutics and Biopharmaceutics

Julie Heremans

Robin Maximilian Awad

Jessica Bridoux

Thomas Ertveldt

Vicky Caveliers

...

2024/3/1

The development of Nanobodies against the next-generation immune checkpoint TIGIT with diagnostic and therapeutic potential

Katty Zeven

Timo De Groof

Geert Raes

Karine Breckpot

Nick Devoogdt

2024/4/18

Immune checkpoints

2024/2/29

Assessment of Connexin43 Hemichannel Functionality Based on Cytosolic Uptake of Yo-Pro1

Raf Van Campenhout

Julen Sanz-Serrano

Axelle Cooreman

Yannick De Vlaeminck

Karine Breckpot

...

2024

Human PD-L1-binding immunoglobulins

2024/1/2

Identification of tumor peptides for therapeutic mRNA vaccination in a mouse multiple myeloma model

Cancer Research

Arne Van der Vreken

Fabien Thery

Sofie Meulewaeter

Karin Vanderkerken

Elke De Bruyne

...

2024/3/22

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

JOURNAL OF CONTROLLED RELEASE

Sofie Meulewaeter

Ilke Aernout

Joke Deprez

Yanou Engelen

Margo De Velder

...

2024

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in acute myeloid leukemia

Cancer Research

Niels Vandewalle

Hatice Satilmis

Emma M Verheye

Rong Fan

Yanmeng Wang

...

2024/3/22

Novel technologies for applying immune checkpoint blockers

International Review of Cell and Molecular Biology

Robin Maximilian Awad

Karine Breckpot

2023/3/30

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for …

Frontiers in Immunology

Heleen Hanssens

Fien Meeus

Yannick De Vlaeminck

Quentin Lecocq

Janik Puttemans

...

2024/4/19

Noninvasive nuclear imaging of the immune checkpoint TIGIT using different nanobody-scaffolds and radionuclides

Katty Zeven

Herlinde Dierick

Matthijs Sevenois

Henri Vincent Baudhuin

Jessica Bridoux

...

2024/3/13

Recent advances using genetic therapies against infectious diseases and for vaccination

Anne Galy

Ben Berkhout

Karine Breckpot

Chantal Pichon

Kristie Bloom

...

2023/9/1

Elevated LAG-3 expression in plasma cells and lymphoid subpopulations at distinct stages of Multiple Myeloma disease progression

Hatice Satilmis

Niels Vandewalle

Emma Verheye

Rong Fan

Elke De Bruyne

...

2023/9/29

In vivo optical imaging of glioma using a novel uPAR-targeting fluorescent single-domain antibody

Lukasz Mateusiak

Sam Floru

Timo De Groof

Noemi Declerck

Janne Wouters

...

2023/3/17

Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

Vaccines

Ignasi Esteban

Carmen Pastor-Quiñones

Lorena Usero

Elena Aurrecoechea

Lorenzo Franceschini

...

2023/12/22

Challenges in neoantigen-directed therapeutics

Lien Lybaert

Steve Lefever

Bruno Fant

Evelien Smits

Bruno De Geest

...

2023/1/9

Phase I study of [68Ga] Ga-Anti-CD206-sdAb for PET/CT assessment of protumorigenic macrophage presence in solid tumors (MMR phase I)

Journal of Nuclear Medicine

Odrade Gondry

Catarina Xavier

Laurens Raes

Johannes Heemskerk

Nick Devoogdt

...

2023/9/1

Accepted poster session at ImmunoRad 2023: Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and …

Thomas Ertveldt

Ahmet Krasniqi

Hannelore Ceuppens

Janik Puttemans

Yana Dekempeneer

...

2023/9/27

The development of radiolabeled nanobodies against the next-generation immune checkpoint TIGIT for non-invasive immune phenotyping of tumors

Katty Zeven

Timo De Groof

Robin Maximilian Awad

Wout De Mey

Thomas Ertveldt

...

2023

Intraoperative tumor visualization through a specific fluorescently-labeled anti-uPAR targeting single-domain antibody

Esaü Vangeloven

Lukasz Mateusiak

Sam Floru

Timo De Groof

Noemi Declerck

...

2023

See List of Professors in Karine Breckpot University(Vrije Universiteit Brussel)

Karine Breckpot FAQs

What is Karine Breckpot's h-index at Vrije Universiteit Brussel?

The h-index of Karine Breckpot has been 42 since 2020 and 62 in total.

What are Karine Breckpot's top articles?

The articles with the titles of

Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels

The development of Nanobodies against the next-generation immune checkpoint TIGIT with diagnostic and therapeutic potential

Immune checkpoints

Assessment of Connexin43 Hemichannel Functionality Based on Cytosolic Uptake of Yo-Pro1

Human PD-L1-binding immunoglobulins

Identification of tumor peptides for therapeutic mRNA vaccination in a mouse multiple myeloma model

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in acute myeloid leukemia

...

are the top articles of Karine Breckpot at Vrije Universiteit Brussel.

What are Karine Breckpot's research interests?

The research interests of Karine Breckpot are: Immunology

What is Karine Breckpot's total number of citations?

Karine Breckpot has 11,282 citations in total.